Myomo

Market context

Myomo is a listed medical robotics company in the wearable exoskeleton lane, with commercial focus on upper-limb orthotics rather than industrial robot platforms.

Facts

• Website: https://myomo.com/
• HQ: Boston, MA, United States
• Ticker: MYO / NYSE American
• Segment: Exoskeleton

Powered upper-limb orthosis company

Myomo develops MyoPro powered arm braces that use EMG sensing and motorized assistance for people with weakened or paralyzed arms and hands.

• Target environment: Rehabilitation clinics, home use, neuromuscular care, stroke recovery, spinal cord injury support and assistive mobility programs.
• Deployment model: Medical robotics model built around prescribed powered orthoses, reimbursement, patient fitting, clinical support and direct patient services.
• Customer context: Patients, clinicians, rehabilitation providers, insurers, veterans programs and investors tracking wearable medical robotics.
• Workflow context: Upper-limb exoskeletons, EMG intent sensing, powered orthotics, arm movement assistance and rehabilitation support.
• Commercial maturity: Commercial medical robotics company with an assistive exoskeleton product line.
• Market position: Public-market wearable medical robotics company.
• Adoption constraints: Adoption depends on reimbursement, clinical referral flow, patient fit, device comfort, training, durability and measured functional benefit.
• Adjacent context: Medical exoskeletons, powered orthoses, rehabilitation robotics, assistive mobility and EMG-controlled wearable devices.
• Source confidence: high

Events

• 2025-04-30 - Product Launch - Myomo launches MyoPro 2x wearable robotics brace - MyoPro 2x focuses on improved donning, fit and function for user independence. The launch expands Myomo’s flagship wearable medical robotics product line after Medicare reimbursement progress. The device targets arm and hand function support for patients with…
• 2024-04-29 - Regulatory - Myomo receives Medicare benefit category determination for MyoPro - Myomo received a final Medicare benefit category determination for the MyoPro powered arm brace. The decision supported reimbursement pathways for a wearable robotic orthosis used by people with upper-limb impairment. The milestone matters because reimburseme…

Team

• Paul R. Gudonis - Chairman and Chief Executive Officer - This role identifies Paul R. Gudonis as part of Myomo's leadership or founding team.

Context tags

• Medical exoskeletons - Peer Group
• Rehab exoskeleton builder - Peer Group
• Intent-based motion control - Capability